| Latest Accentia Biopharmaceuticals News Headlines | | Date | Time | Source | | | 07/18/2008 | 9:20AM | PRNUS | BeaconEquity.com Issues TraderNotes on Active Stocks: MNLU, DELL, WAHCU, RUTH, ABPI, CATS
DALLAS, July 18 /PRNewswire/ -- BeaconEquity.com announces the availability of TraderNotes on stocks making news today.
Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m
Today's TraderNotes include: Mainland Resources Inc. (OTC:MNLU) (BULLETIN BOARD: MNLU) , Dell... More...>> |
| 06/12/2008 | 3:00AM | PRNUS | BeaconEquity.com Issues Trader Notes on BCFT, ABPI, AGU, MCHP, DSCO, AMAT, NVDA, SPLS
DALLAS, June 12 /PRNewswire/ -- BeaconEquity.com announces the availability of TraderNotes on stocks making news today.
Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m
Today's TraderNotes include: Bancroft Uranium Inc. (OTC:BCFT) (BULLETIN BOARD: BCFT) , Accentia... More...>> |
| 07/11/2006 | 7:00AM | PRNUS | CHMS, ABPI, ATML and EVOL Update the Investment Community in All New Interviews With WallSt.net
NEW YORK, July 11 /PRNewswire/ -- On June 16, Angela Du, President of China Mobility Solutions, Inc. (OTC:CHMS) (BULLETIN BOARD: CHMS) updated the investment community in an all-new interview with http://www.wallst.net/ . Interview highlights include detailed discussions on the following topics:
- key drivers... More...>> |
| 06/20/2006 | 11:00AM | PRNUS | Inyx's Exaeris, Inc. Co-launches MD Turbo(TM) in the United States
Device Intended to Help Make Asthma Inhalers Easier to Coordinate and More Accurately Track Doses
EXTON, Pa., June 20 /PRNewswire-FirstCall/ -- Exaeris, Inc., a wholly owned subsidiary of Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , announced today that it has initiated its commercial launch to physicians in the United... More...>> |
| 04/12/2006 | 8:35AM | PRNUS | Inyx's Exaeris, Inc. and Accentia BioPharmaceuticals, Inc. Sign Co-Promotion Agreement for MD Turbo(TM)
EXTON, Pa., and TAMPA, Fla., April 12 /PRNewswire-FirstCall/ -- Exaeris, Inc., a wholly owned subsidiary of Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , and TEAMM Pharmaceuticals, Inc., the specialty pharmaceutical division of Accentia BioPharmaceuticals, Inc. (NASDAQ:ABPI), announced today that they have finalized... More...>> |
|